Real World' Registry for 'PCB Only' in De Novo Lesions
Real World' Registry for 'PCB Only' in De Novo Lesions
The current registry data revealed a high procedural success rate for PCB angioplasty and a low 9-month TLR rate. Our findings agree well with the results of the randomised BELLO study and support the 'PCB only' strategy to treat de novo lesions in small vessels without additional stenting.
Conclusions
The current registry data revealed a high procedural success rate for PCB angioplasty and a low 9-month TLR rate. Our findings agree well with the results of the randomised BELLO study and support the 'PCB only' strategy to treat de novo lesions in small vessels without additional stenting.
Source...